Dr. Cantor’s research is focused on identifying biological problems that are resistant to conventional analytical approaches and then developing new methodologies or techniques for solving these problems. His laboratory has developed methods for separating large DNA molecules, for studying structural relationships in complex assemblies of proteins and nucleic acids, and for sensitive detection of proteins and nucleic acids in a variety of settings. His current interests include the development of new methods for faster DNA sequencing, the development of new variations and analogs of the polymerase chain reaction, the development of bacterial strains suitable for environmental detoxification, and the discovery of human genes associated with sense and taste. He is also interested in exploring the possible use of biological molecules for applications in nanoengineering and microrobotics, and in making detectors capable of recognizing specific single molecules.
Dr. Charles Cantor Professor Emeritus at Boston University, Co-Founder of Sequenom Inc., Co-Founder of Retrotope Inc. Former Principal Scientist of Human Genome Project, Department of Energy, Co-founder of Sequenom (acquired by LabCorp), Professor and Director of the Center for Advanced Biotechnology, Boston University